LUMEVOQ® from GenSight Biologics is a gene therapy developed for the treatment of Leber Hereditary Optic Neuropathy (LHON), a rare blinding disease marked by sudden, irreversible vision loss.
The name LUMEVOQ®, developed by Origin is visually distinct with powerful messaging, being derived from ‘illuminate’ and ‘evoke’, overall the name suggests rescuing vision, clarity and speed.